Compare Stocks

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APHA Aphria	$15.38	$15.48	$2.78 ▼ $32.29	$4.87B	2.67	21.83 million shs	N/A
CGC Canopy Growth	$7.93 +1.3%	$5.40	$2.76 ▼ $19.20	$722.50M	1.39	9.84 million shs	12.54 million shs
CRON Cronos Group	$2.37 -1.7%	$2.32	$1.64 ▼ $2.99	$905.36M	1.17	2.90 million shs	3.87 million shs
STDAF STADA Arzneimittel Aktiengesellschaft	$110.42	$110.42	$75.15 ▼ $115.00	$6.88B	0.38	180 shs	N/A
TLRY Tilray	$1.73 +0.6%	$1.96	$1.50 ▼ $3.40	$1.28B	2.36	29.53 million shs	20.58 million shs

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APHA Aphria	0.00%	0.00%	0.00%	0.00%	0.00%
CGC Canopy Growth	+20.65%	-3.93%	+104.44%	+79.18%	-45.24%
CRON Cronos Group	-0.41%	-5.12%	+5.24%	+20.50%	+24.23%
STDAF STADA Arzneimittel Aktiengesellschaft	0.00%	0.00%	0.00%	0.00%	0.00%
TLRY Tilray	0.00%	-9.47%	-10.42%	-14.00%	-28.63%

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APHA Aphria	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CGC Canopy Growth	0.821 of 5 stars	0.8	2.0	0.0	0.0	3.8	0.0	1.3
CRON Cronos Group	1.6866 of 5 stars	2.2	5.0	0.0	0.0	3.3	0.0	1.3
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	1.289 of 5 stars	3.1	2.0	0.0	0.0	2.2	0.0	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APHA Aphria	N/A	N/A	N/A	N/A
CGC Canopy Growth	1.50	Reduce	$4.87	-38.63% Downside
CRON Cronos Group	2.33	Hold	$2.83	19.55% Upside
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A
TLRY Tilray	2.25	Hold	$2.71	56.55% Upside

Current Analyst Ratings

Latest CGC, STDAF, APHA, CRON, and TLRY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/10/2024	TLRY Tilray	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$4.25 ➝ $4.00
4/10/2024	TLRY Tilray	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$2.25 ➝ $2.00
4/8/2024	CRON Cronos Group	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$2.00 ➝ $2.50
4/5/2024	TLRY Tilray	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral	$2.25 ➝ $2.75
2/12/2024	CGC Canopy Growth	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underperform	$5.00 ➝ $3.00
1/31/2024	CGC Canopy Growth	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Perform	$5.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APHA Aphria	$405.96M	12.00	$0.09 per share	166.43	$4.80 per share	3.20
CGC Canopy Growth	$304.79M	2.37	N/A	N/A	$11.14 per share	0.71
CRON Cronos Group	$87.24M	10.38	N/A	N/A	$2.87 per share	0.83
STDAF STADA Arzneimittel Aktiengesellschaft	$3.84B	1.79	$11.12 per share	9.93	$23.11 per share	4.78
TLRY Tilray	$627.12M	2.05	$0.00 per share	1,895.02	$4.50 per share	0.38

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APHA Aphria	-$63.21M	-$0.06	N/A	219.71	N/A	-36.10%	-2.30%	-1.66%	N/A
CGC Canopy Growth	-$2.48B	-$15.12	N/A	N/A	N/A	-326.75%	-73.48%	-27.82%	6/27/2024 (Estimated)
CRON Cronos Group	-$73.96M	-$0.19	N/A	79.00	N/A	-84.15%	-3.99%	-3.87%	5/14/2024 (Estimated)
STDAF STADA Arzneimittel Aktiengesellschaft	$292.15M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	-$1.45B	-$0.44	N/A	N/A	N/A	-43.98%	-2.68%	-2.09%	7/24/2024 (Estimated)

Latest CGC, STDAF, APHA, CRON, and TLRY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/29/2024	Q4 2023	CRON Cronos Group	N/A	-$0.05	-$0.05	$0.02	$25.15 million	$23.92 million
2/9/2024	Q3 2024	CGC Canopy Growth	-$0.45	-$1.79	-$1.34	-$1.66	$53.25 million	$57.67 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APHA Aphria	N/A	N/A	N/A	N/A	N/A
CGC Canopy Growth	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APHA Aphria	0.25	2.36	1.17
CGC Canopy Growth	0.96	1.79	1.40
CRON Cronos Group	N/A	22.54	21.81
STDAF STADA Arzneimittel Aktiengesellschaft	2.23	1.54	0.99
TLRY Tilray	0.11	1.92	1.18

Ownership

Institutional Ownership

Company	Institutional Ownership
APHA Aphria	10.30%
CGC Canopy Growth	3.33%
CRON Cronos Group	8.71%
STDAF STADA Arzneimittel Aktiengesellschaft	N/A
TLRY Tilray	9.35%

Insider Ownership

Company	Insider Ownership
APHA Aphria	N/A
CGC Canopy Growth	0.35%
CRON Cronos Group	1.96%
STDAF STADA Arzneimittel Aktiengesellschaft	N/A
TLRY Tilray	0.68%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
APHA Aphria	1,200	316.80 million	N/A	Optionable
CGC Canopy Growth	1,621	91.11 million	90.80 million	Optionable
CRON Cronos Group	356	382.01 million	374.52 million	Optionable
STDAF STADA Arzneimittel Aktiengesellschaft	12,500	62.34 million	N/A	Not Optionable
TLRY Tilray	1,600	742.72 million	737.67 million	Optionable

CGC, STDAF, APHA, CRON, and TLRY Headlines

Source	Headline
	Tilray (NASDAQ:TLRY) Shares Down 0.3% marketbeat.com - April 19 at 1:37 PM
	Tilray (NASDAQ:TLRY) Stock Price Up 3.8% marketbeat.com - April 18 at 3:41 PM
	Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation finance.yahoo.com - April 18 at 9:57 AM
	Montauk Brewing's Project 4:20 IPA Returns to Support Surfrider Foundation globenewswire.com - April 18 at 8:00 AM
	Latest News for Tilray Brands Stock (NASDAQ:TLRY) benzinga.com - April 18 at 4:56 AM
	Tilray (NASDAQ:TLRY) Trading Down 4.9% marketbeat.com - April 17 at 1:11 PM
	The Best Cannabis Stock to Invest $1,000 in Right Now fool.com - April 17 at 7:45 AM
	Tilray Brands Lights Up 420 With Music Festivals and Celebrations Across The Country finance.yahoo.com - April 17 at 7:32 AM
	What's Going On With Marijuana Grower Tilray's Stock? msn.com - April 16 at 4:10 PM
	Tilray (NASDAQ:TLRY) Trading Up 2% marketbeat.com - April 16 at 2:58 PM
	April 2024's Hot Picks: Top Canadian Cannabis Stocks To Watch Now marijuanastocks.com - April 16 at 9:00 AM
	Tilray Brands Missed on Revenue in Q3, but This Is the More Concerning Number for Investors fool.com - April 16 at 7:15 AM
	3 Cannabis Penny Stocks to Buy for 3-Bagger Returns investorplace.com - April 16 at 6:45 AM
	Tilray (NASDAQ:TLRY) Trading Up 0.8% marketbeat.com - April 15 at 3:58 PM
	3 Pot Stocks That Could Make You a Cannabis Millionaire investorplace.com - April 15 at 11:20 AM
	FY2024 Earnings Estimate for Tilray Inc Issued By Roth Capital (NASDAQ:TLRY) americanbankingnews.com - April 15 at 1:34 AM
	Tilray (NASDAQ:TLRY) Trading Down 0.5% americanbankingnews.com - April 14 at 4:36 AM
	FY2024 Earnings Estimate for Tilray Inc (NASDAQ:TLRY) Issued By Alliance Global Partners americanbankingnews.com - April 13 at 2:54 AM
	Analysts Set Tilray Inc (NASDAQ:TLRY) Target Price at $2.88 americanbankingnews.com - April 13 at 2:00 AM
	Tilray (NASDAQ:TLRY) Shares Down 0.5% marketbeat.com - April 12 at 2:50 PM
	Is TLRY Stock A Buy As Tilray Plunges On Results And 4/20 Rolls Around? finance.yahoo.com - April 12 at 1:47 PM
	Is TLRY Stock A Buy As Tilray Plunges On Results And 4/20 Rolls Around? investors.com - April 12 at 10:08 AM
	These Marijuana Stocks Could Begin To Rise Again? marijuanastocks.com - April 12 at 9:10 AM
	Why Tilray Brands Stock Fell 26.9% This Week fool.com - April 12 at 7:22 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Micron Technology Results Proves AI is Driving Storage Demand
March 26, 2024 7:35 AM
View Micron Technology Results Proves AI is Driving Storage Demand
Micron Is the NVIDIA of Memory Chips: Here’s Why
March 21, 2024 10:15 AM
View Micron Is the NVIDIA of Memory Chips: Here’s Why
Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
April 10, 2024 10:42 AM
View Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
Cannabis: One Stock to Play the Movement
April 8, 2024 8:38 AM
View Cannabis: One Stock to Play the Movement
Tencent Is Looking to Fill Nvidia’s Gap in China’s Chip Market
March 25, 2024 4:41 PM
View Tencent Is Looking to Fill Nvidia’s Gap in China’s Chip Market

All Headlines

Company Descriptions

Aphria

NASDAQ:APHA

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Canopy Growth

NASDAQ:CGC

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Cronos Group

NASDAQ:CRON

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

STADA Arzneimittel Aktiengesellschaft

OTCMKTS:STDAF

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

Tilray

NASDAQ:TLRY

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial